Available and Ongoing Clinical Trials for Parkinson’s Disease Patients.

Slides:



Advertisements
Similar presentations
Evaluation of Movement Disorders
Advertisements

Medium-term prognosis of an incident cohort of people with Parkinson’s and their carers vs a community-based control group Carl Counsell.
Parkinson’s Disease (PD)
MDS-PAS School for Young Neurologists Video Dinner February 21, 2015 Maria Eliza T. Freitas, MD Clinical Fellow In Movement Disorder University of Toronto.
Advances in Lung Transplantation: A Patient Guide David J. Lederer, M.D., M.S. Assistant Professor of Medicine New York Presbyterian Lung Transplant Program.
Copyright © 2014 by Mosby, an imprint of Elsevier Inc.
Diagnosis and Treatment of Parkinson’s Disease Jeff Bronstein, MD, PhD Professor of Neurology at UCLA Director of the SW PADRECC Director of UCLA Movement.
Parkinson’s Disease Historical Perspective  First described by British doctor James Parkinson  Identified its major symptoms and called it “the shaking.
Primary Symptoms It is important to note that not all patients experience the full range of symptoms; in fact, most do not. Rigidity is an increased tone.
Initial Diagnosis and Management of Parkinson’s Disease
The Brain. Problems with the Brain… Dementia – group of symptoms affecting intellectual and social abilities severely enough to interfere with daily.
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
Severe and Persistent Mental Illness and Mothers A Mothers’ Mental Health Toolkit Project Learning Video with Dr. Joanne MacDonald Reproductive Mental.
The Surgical Treatment of Parkinson’s Disease
Neurodegeneration is the umbrella term for the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative.
Pharmacological Management. Only symptomatic treatment, there is no cure. Acetylcholinesterase inhibitors - Only for mild to moderate dementia –Donepezil.
Duodenal Levodopa Treatment in advanced Parkinson’s Disease
Parkinson’s Plus By: Glen Estrosos.
Treatment of Parkinson’s Disease Thomas L. Davis, M.D. Associate Professor of Neurology Vanderbilt School of Medicine.
MODELING THE PARKINSONIAN TREMOR AND ITS TREATMENT Supervisor : Dr Towhidkhah Designed by Yashar Sarbaz Amirkabir University of Technology.
Surgery for Parkinson’s Disease: Focus on Deep Brain Stimulation Ramón L Rodríguez, MD Director of Clinical Services University of Florida Movement Disorders.
PARKINSON’S DISEASE By Courtney and Niral. WHAT IS IT?  Parkinson's disease (PD) is chronic and progressive movement disorder, meaning that symptoms.
Treatment of Parkinson Disease David Tran, 2013 Mercer University PharmD Candidate.
Benjamin L. Walter M.D. Medical Director, Deep Brain Stimulation Program Neurological Institute University Hospitals Case Medical Center Management of.
Parkinson’s Disease by Jessica Teen Health 8 Definition *Parkinson’s Disease is a disorder of the brain characterized by shaking and having difficulty.
Parkinson’s Disease. 1817: Dr. James Parkinson: What is Parkinson’s Disease?
NEUROLOGICAL DISORDERS. Dementia  A degenerative syndrome characterized by deficits in memory, language, and mood.  The most common form: Alzheimer’s.
PARKINSON’S DISEASE BY: NICOLE MABARDI & SHAINA JOSEPH.
Neurological Disorders
Psychosis in Dementia Conclusions Psychosis in dementia is distressful and disturbing to patients and  Is similar across the spectrum of the dementia.
Recent Advances in the cause and treatment of Parkinson disease
By Katelyn Chaimson and Sean Guyot
Parkinson's disease By Colby Allen. symptoms Mild to major tremors. Rigidity or joint stiffness Bradykinesia or slowness of movement Postural instability.
Parkinson’s Disease Angela Duncan June Why I Chose This Subject Common neurodegenerative disorder / in Scotland Expected increase.
Drugs Used for Parkinson’s Disease Chapter 15 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Pharmacological Treatment of Parkinson Disease: A.
How is Parkinson’s disease Diagnosed? And What Are the Treatment options?
Partners in Progress: Deciding to Participate in Parkinson’s Clinical Research.
PARKINSON’S DISEASE LUKE CARROLL & LAUREN DESROCHES.
When the going gets tough…. How to select patients with Parkinson’s disease for advanced therapies Dr Paul Worth PhD FRCP Consultant Neurologist, Addenbrooke’s.
Drugs Used for Parkinson’s Disease
Dementia with Lewy Bodies
Involuntary movements in Parkinson’s disease: not always what it seems
Agitation Medication  Side Effects Follow Up and Documentation
Antipsychotics academic detailing
Expert Perspectives on New Treatment Options for Parkinson Disease Psychosis.
The Nurse View: Management of Pancreatic Cancer
Better Lives. Together. The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward.
Drugs for Parkinson’s Disease
Falon Fiorillo & Breeanna Fournier
“The effects of chronic changes to the functioning of the nervous system due to interference to neurotransmitter function, illustrated by the role of Dopamine.
Glaucoma.
Motor Fluctuations in Parkinson Disease: Options and Strategies
Parkinson Disease:.
New Insights Into Neurogenic Orthostatic Hypotension
The Parkinson's Disease Psychosis Journal Club
Copyright © 2004 American Medical Association. All rights reserved.
WHAT I NEED TO KNOW AS A PATIENT AND A CAREGIVER
Treating to Target in MS
Treating CD30-Expressing Cutaneous T-Cell Lymphoma
Parkinson Disease Psychosis
MODELING THE PARKINSONIAN TREMOR AND ITS TREATMENT
Are We Making Progress in the Management of Huntington Disease?
Wearing Off in Parkinson Disease: The Value of New Generation COMT Inhibition.
Parkinson’s Disease Definitions Disease features Pathology
Deep Brain Stimulation: What, When, Why, How
Clinical response to anti-ERBB3 mAb therapy in a patient with an advanced NRG1-rearranged non–small cell lung cancer. Clinical response to anti-ERBB3 mAb.
supported study by Dr. Heiko Gaßner and Dr. Cecilia Raccagni
Conceptual diagram of dopaminergic system and disease and drug effects
Understanding the Basics of Dementia-Related Psychosis
Presentation transcript:

Available and Ongoing Clinical Trials for Parkinson’s Disease Patients

EARLY PD Rasagiline – may slow progression of PD Rasagiline – may slow progression of PD In a preliminary delayed start study those who took rasagiline from the beginning did better than those who started it after 6 months In a preliminary delayed start study those who took rasagiline from the beginning did better than those who started it after 6 months Istradefylline – may improve PD symptoms without causing dyskinesia Istradefylline – may improve PD symptoms without causing dyskinesia

EARLY PD STRIDE and FIRST STEP – evaluate Stalevo vs. Sinemet with regard to: STRIDE and FIRST STEP – evaluate Stalevo vs. Sinemet with regard to: Does Stalevo improve PD more than Sinemet? Does Stalevo improve PD more than Sinemet? Does Stalevo cause less dyskinesia? Does Stalevo cause less dyskinesia? Does Stalevo lower homocysteine? Elevations of homocysteine may cause strokes and be associated with dementia Does Stalevo lower homocysteine? Elevations of homocysteine may cause strokes and be associated with dementia CoQ10 CoQ10 May slow progression of disease May slow progression of disease Stabilizes energy production in cells Stabilizes energy production in cells

MODERATE PD Glutathione – antioxidant Glutathione – antioxidant May improve symptoms May improve symptoms May slow progression May slow progression Eye Safety Study Eye Safety Study Tests eyesight while taking Parkinson Disease medications Tests eyesight while taking Parkinson Disease medications

ADVANCED PD Istradefylline – for patients with fluctuations Istradefylline – for patients with fluctuations Spheramine – transplantation of retinal cells Spheramine – transplantation of retinal cells These cells make levodopa and serve as levodopa pumps in the brain These cells make levodopa and serve as levodopa pumps in the brain for pts with moderate – severe symptoms in the morning before taking medication for pts with moderate – severe symptoms in the morning before taking medication Sarizotan – for dyskinesia Sarizotan – for dyskinesia

OTHER Fatigue Study Fatigue Study Try to understand and treat potential causes of fatigue in PD Try to understand and treat potential causes of fatigue in PD Psychosis Study Psychosis Study Evaluating the use of Melperone (an antipsychotic) in PD patients with psychosis Evaluating the use of Melperone (an antipsychotic) in PD patients with psychosis SPECT scan studies SPECT scan studies Develop a scan as a diagnostic tool to discern between Parkinsonian and non-Parkinsonian tremor Develop a scan as a diagnostic tool to discern between Parkinsonian and non-Parkinsonian tremor

If interested in clinical trials, please call: or